All Pharma News
Flemming mulls IPO for Galderma; Reistone shows results from eczema study

Flemming mulls IPO for Galderma; Reistone shows results from eczema study
Paul Schloesser\nAmber Tong ENDPTS
11 Oct 2021
Share Share
FDA offers support for Takeda`s potential cytomegalovirus drug

FDA offers support for Takeda`s potential cytomegalovirus drug
Z. Brennan ENDPTS
07 Oct 2021
Share Share
Delix snags $70M series A for psychedelic analog trials in 2022

Delix snags $70M series A for psychedelic analog trials in 2022
Kyle LaHucik FIERCEBIOTECH
27 Sep 2021
Share Share
Takeda bags Japanese rights to maralixibat; Boehringer acquires Abexxa Biologics

Takeda bags Japanese rights to maralixibat; Boehringer acquires Abexxa Biologics
Paul Scloesser\nNicole DeFeudis ENDPTS
21 Sep 2021
Share Share
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit

AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit
Eric Sagonowsky FIERCEPHARMA
15 Sep 2021
Share Share
Takeda offloads heart, metabolic drugs in China for $322M

Takeda offloads heart, metabolic drugs in China for $322M
Angus Liu FIERCE PHARMA
24 Dec 2020
Share Share
Is Takeda’s post-Shire sell-off approaching its final days?

Is Takeda’s post-Shire sell-off approaching its final days?
Jason Mast ENDPOINTSNEWS
20 Aug 2020
Share Share
Takeda poised to cut sales jobs in Japan as restructuring continues

Takeda poised to cut sales jobs in Japan as restructuring continues
PHARMAFILE
29 Jul 2020
Share Share
Takeda’s post-merger deals continue as OTC subsidiary is prepared for sale

Takeda’s post-merger deals continue as OTC subsidiary is prepared for sale
Max Gelman ENDPTS
08 Jul 2020
Share Share
Novartis pulls Takeda-bought dry eye med Xiidra in Europe

Novartis pulls Takeda-bought dry eye med Xiidra in Europe
Angus Liu FIERCE PHARMA
27 Jun 2020
Share Share